House com­mit­tee ad­vances key PBM bills in step with Sen­ate coun­ter­parts

The House En­er­gy & Com­merce Com­mit­tee on Wednes­day ad­vanced sev­er­al pieces of leg­is­la­tion seek­ing to re­quire more trans­paren­cy from phar­ma­cy ben­e­fit man­agers, mov­ing them one step clos­er to be­com­ing law.

Dur­ing an ex­pan­sive full com­mit­tee markup of more than 40 bills, the law­mak­ers con­sid­ered a slate of health­care pro­pos­als, in­clud­ing leg­is­la­tion that would al­low for Medicare flex­i­bil­i­ties for cov­er­ing biosim­i­lars and putting up guardrails around PBM com­pen­sa­tion prac­tices.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER